Guillain‐Barre syndrome secondary to COVID‐19 infection: A case report

Guillain‐Barre syndrome (GBS) is a rare autoimmune disease that often manifests as a post‐viral complication. However, its association with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is unclear. We present a rare case of GBS secondary to COVID‐19 infection complicated by rapidly pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Dena H., Basra, Dalwinder, Bilgrami, Zaid, Challa, Suryanarayana R., Kwon, Christina, Marciniak, Ellen, Verceles, Avelino C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062311/
https://www.ncbi.nlm.nih.gov/pubmed/37006840
http://dx.doi.org/10.1002/ccr3.7104
Descripción
Sumario:Guillain‐Barre syndrome (GBS) is a rare autoimmune disease that often manifests as a post‐viral complication. However, its association with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is unclear. We present a rare case of GBS secondary to COVID‐19 infection complicated by rapidly progressive sensorimotor deterioration resistant to plasma exchange therapy.

Ejemplares similares